New Results
Alternative splicing liberates a cryptic cytoplasmic isoform of mitochondrial MECR that antagonizes influenza virus
View ORCID ProfileSteven F. Baker, Helene Meistermann, Manuel Tzouros, View ORCID ProfileAaron Baker, Sabrina Golling, Juliane Siebourg Polster, Mitchell P. Ledwith, View ORCID ProfileAnthony Gitter, Angelique Augustin, Hassan Javanbakht, View ORCID ProfileAndrew Mehle
doi: https://doi.org/10.1101/2020.11.09.355982
Steven F. Baker
1Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, USA
Helene Meistermann
2Roche Pharma Research and Early Development, Pharmaceutical Sciences – Biomarkers, Bioinformatics and Omics & Pathology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
Manuel Tzouros
2Roche Pharma Research and Early Development, Pharmaceutical Sciences – Biomarkers, Bioinformatics and Omics & Pathology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
Aaron Baker
3Department of Computer Sciences, University of Wisconsin-Madison
4Morgridge Institute for Research, Madison, Wisconsin
Sabrina Golling
2Roche Pharma Research and Early Development, Pharmaceutical Sciences – Biomarkers, Bioinformatics and Omics & Pathology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
Juliane Siebourg Polster
2Roche Pharma Research and Early Development, Pharmaceutical Sciences – Biomarkers, Bioinformatics and Omics & Pathology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
Mitchell P. Ledwith
1Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, USA
Anthony Gitter
3Department of Computer Sciences, University of Wisconsin-Madison
4Morgridge Institute for Research, Madison, Wisconsin
5Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison
Angelique Augustin
2Roche Pharma Research and Early Development, Pharmaceutical Sciences – Biomarkers, Bioinformatics and Omics & Pathology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
Hassan Javanbakht
6Roche Pharma Research and Early Development, Infectious Diseases, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
Andrew Mehle
1Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, USA
Posted November 10, 2020.
Alternative splicing liberates a cryptic cytoplasmic isoform of mitochondrial MECR that antagonizes influenza virus
Steven F. Baker, Helene Meistermann, Manuel Tzouros, Aaron Baker, Sabrina Golling, Juliane Siebourg Polster, Mitchell P. Ledwith, Anthony Gitter, Angelique Augustin, Hassan Javanbakht, Andrew Mehle
bioRxiv 2020.11.09.355982; doi: https://doi.org/10.1101/2020.11.09.355982
Alternative splicing liberates a cryptic cytoplasmic isoform of mitochondrial MECR that antagonizes influenza virus
Steven F. Baker, Helene Meistermann, Manuel Tzouros, Aaron Baker, Sabrina Golling, Juliane Siebourg Polster, Mitchell P. Ledwith, Anthony Gitter, Angelique Augustin, Hassan Javanbakht, Andrew Mehle
bioRxiv 2020.11.09.355982; doi: https://doi.org/10.1101/2020.11.09.355982
Subject Area
Subject Areas
- Biochemistry (11715)
- Bioengineering (8723)
- Bioinformatics (29129)
- Biophysics (14936)
- Cancer Biology (12049)
- Cell Biology (17359)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14144)
- Epidemiology (2067)
- Evolutionary Biology (18268)
- Genetics (12221)
- Genomics (16767)
- Immunology (11843)
- Microbiology (28014)
- Molecular Biology (11560)
- Neuroscience (60814)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10384)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)